开云app官网登录入口网页版-官方正版

#CCB#

9篇内容 | 1517人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2144640, encodeId=dc8c2144640f5, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a><a href='/topic/show?id=74e818333c' target=_blank style='color:#2F92EE;'>#ACEI#</a>、<a href='/topic/show?id=c24e2e2076' target=_blank style='color:#2F92EE;'>#ARB#</a>和<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>都能降低主要<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>的风险。<a href='/topic/show?id=573332291bd' target=_blank style='color:#2F92EE;'>#利尿剂#</a>表现出类似的趋势，而β-受体阻滞剂和肾素抑制剂则没有。就依从性而言，ARB和CCB与安慰剂相当，而ACEI、<a href='/topic/show?id=6ebe1918eb0' target=_blank style='color:#2F92EE;'>#β-受体阻滞剂#</a>和<a href='/topic/show?id=ab6b19130b3' target=_blank style='color:#2F92EE;'>#α-受体阻滞剂#</a>与安慰剂和其他药物相比明显更容易出现中止治疗。, objectTitle=ESH 2023 重磅开启 | 一文尽览！多项高血压重磅研究结果公布！, objectType=article, longId=778450, objectId=d670e784505c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230619/50a9c31b1fcd4b97bc867ef7fe6e7093.jpg, objectUrl=/article/show_article.do?id=d670e784505c, replyNumber=1, likeNumber=142, createdTime=2023-06-25, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d670e784505c, moduleTitle=ESH 2023 重磅开启 | 一文尽览！多项高血压重磅研究结果公布！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d670e784505c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1396165, encodeId=e5841396165a8, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！, objectType=article, longId=219177, objectId=f3342191e7d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3342191e7d0, replyNumber=0, likeNumber=99, createdTime=2021-10-25, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3342191e7d0, moduleTitle=目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f3342191e7d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396164, encodeId=e27713961643e, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关, objectType=article, longId=218085, objectId=3d5a21808537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5a21808537, replyNumber=0, likeNumber=94, createdTime=2021-10-05, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5a21808537, moduleTitle=Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3d5a21808537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396163, encodeId=98ba13961638b, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=【2017海峡会】GAP-CCBC：继承传帮带传统，从实践中培养智慧医生, objectType=article, longId=120552, objectId=8520120552c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8520120552c3, replyNumber=0, likeNumber=114, createdTime=2017-11-19, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8520120552c3, moduleTitle=【2017海峡会】GAP-CCBC：继承传帮带传统，从实践中培养智慧医生, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8520120552c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396162, encodeId=6a58139616285, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=CCB：利用光来诱发细胞自我毁灭或有望开发多种疾病的新型疗法, objectType=article, longId=87025, objectId=69388e02586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69388e02586, replyNumber=0, likeNumber=131, createdTime=2017-01-10, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69388e02586, moduleTitle=CCB：利用光来诱发细胞自我毁灭或有望开发多种疾病的新型疗法, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=69388e02586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396161, encodeId=82931396161b1, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, objectType=article, longId=61921, objectId=f1336192167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1336192167, replyNumber=0, likeNumber=90, createdTime=2016-01-11, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1336192167, moduleTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f1336192167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396160, encodeId=85bf139616027, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=BMJ：计算机化的认知行为治疗（cCBT）对改善抑郁症没有效果, objectType=article, longId=58757, objectId=178858e57f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=178858e57f9, replyNumber=0, likeNumber=116, createdTime=2015-11-14, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=178858e57f9, moduleTitle=BMJ：计算机化的认知行为治疗（cCBT）对改善抑郁症没有效果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=178858e57f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396159, encodeId=324e1396159e9, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=Am J Cardiol：ARB或许比CCB对糖尿病合并高血压患者保护效应更优, objectType=article, longId=24845, objectId=c22c24845fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c22c24845fd, replyNumber=0, likeNumber=86, createdTime=2013-09-25, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c22c24845fd, moduleTitle=Am J Cardiol：ARB或许比CCB对糖尿病合并高血压患者保护效应更优, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c22c24845fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1396158, encodeId=b66e13961581d, content=<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>, objectTitle=Kidney Int：对伴CKD的老年高血压患者 ARB联合CCB预防心血管事件优于大剂量ARB, objectType=article, longId=14436, objectId=922c1443662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922c1443662, replyNumber=0, likeNumber=119, createdTime=2013-01-16, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922c1443662, moduleTitle=Kidney Int：对伴CKD的老年高血压患者 ARB联合CCB预防心血管事件优于大剂量ARB, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=922c1443662)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

CCB

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

全文收起 #高血压##ACEI#、#ARB#和#CCB#都能降低主要#心血管事件#的风险。#利尿剂#表现出类似的趋势，而β-受体阻滞剂和肾素抑制剂则没有。就依从性而言，ARB和CCB与安慰剂相当，而ACEI、#β-受体阻滞剂#和#α-受体阻滞剂#与安慰剂和其他药物相比明显更容易出现中止治疗。

ESH 2023 重磅开启 | 一文尽览！多项高血压重磅研究结果公布！

2023-06-25发表于上海

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

目前中国**BB+CCB长效单片复方制剂上市！促进中国高血压治疗血压心率双管理！

2021-10-25

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

Hypertension：基于ACEI和CCB的治疗或与中高风险高血压患者更好的血压控制有关

2021-10-05

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

【2017海峡会】GAP-CCBC：继承传帮带传统，从实践中培养智慧医生

2017-11-19

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

CCB：利用光来诱发细胞自我毁灭或有望开发多种疾病的新型疗法

2017-01-10

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs

2016-01-11

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

BMJ：计算机化的认知行为治疗（cCBT）对改善抑郁症没有效果

2015-11-14

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

Am J Cardiol：ARB或许比CCB对糖尿病合并高血压患者保护效应更优

2013-09-25

智者为医08 (审核中...)

前往app查看评论内容

#CCB#

Kidney Int：对伴CKD的老年高血压患者 ARB联合CCB预防心血管事件优于大剂量ARB

2013-01-16

科室
- - 订阅+
  - 更多科室
工具
服务